Agilent RapidFire 400: A Complete Approach To High-Throughput Mass Spectrometry

High-throughput laboratories depend on robust instrumentation to ensure productivity while managing thousands of samples per day. The Agilent RapidFire has been delivering reliable mass spec results in these challenging environments, over a broad range of applications, for more than 14 years.

Presenter: Kevin McCann (Product Owner, Agilent Technologies, Inc.)

As a Product Owner at Agilent, Kevin helps develop and implent high-throughput LC/MS technologies including StreamSelect and RapidFire. He has also worked as an application scientist, working with a team focused on developing and supporting a variety of LC/MS applications. Prior to his work at Agilent, Kevin was the laboratory manager of the biochemical genetics laboratory at Mount Sinai Hospital in New York where he also developed MS methods for TDM of tamoxifen, acylcarnitine profiles, and amino acid profiles.

Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years. In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until it was acquired by Beckman Coulter. Kevin also managed the R&D for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters. When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoy boating, skiing, and gardening.